Aurora Cannabis Stock Forecast, Price & News

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 4 sell ratings and 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "sell" Aurora Cannabis stock.
View analyst ratings for Aurora Cannabis or view top-rated stocks.

Wall Street analysts have given Aurora Cannabis a "Sell" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aurora Cannabis wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Tuesday, September 21st 2021.
View our earnings forecast for Aurora Cannabis.

Aurora Cannabis Inc. (TSE:ACB) announced its earnings results on Monday, May, 15th. The company reported ($0.01) earnings per share for the quarter, hitting the consensus estimate of ($0.01). The company had revenue of $5.18 million for the quarter, compared to analysts' expectations of $7.44 million.
View Aurora Cannabis' earnings history.

Aurora Cannabis' stock was trading at C$1.17 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ACB stock has increased by 607.7% and is now trading at C$8.28.
View which stocks have been most impacted by COVID-19.

7 brokerages have issued 1-year price objectives for Aurora Cannabis' stock. Their forecasts range from C$6.00 to C$14.00. On average, they expect Aurora Cannabis' share price to reach C$9.10 in the next twelve months. This suggests a possible upside of 9.9% from the stock's current price.
View analysts' price targets for Aurora Cannabis or view top-rated stocks among Wall Street analysts.

Some companies that are related to Aurora Cannabis include Hikma Pharmaceuticals (HIK), Aphria (APHA), The Hydropothecary (THCX), OrganiGram (OGI), HEXO (HEXO), Knight Therapeutics (GUD), HLS Therapeutics (HLS), Amryt Pharma (AMYT), Benchmark (BMK), The Supreme Cannabis (FIRE), ESSA Pharma (EPI), Leaf Mobile (LEAF), ICC Labs (ICC), Medexus Pharmaceuticals (MDP) and Science in Sport (SIS).
View all of ACB's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include (CGC), Canopy Growth (WEED), Aphria (APHA), OrganiGram (OGI), Aurora Cannabis (ACBFF), Cronos Group (CRON), Micron Technology (MU), Alibaba Group (BABA), The Green Organic Dutchman (TGOD) and Advanced Micro Devices (AMD).

Aurora Cannabis trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ACB."

Shares of ACB and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

One share of ACB stock can currently be purchased for approximately C$8.28.

Aurora Cannabis has a market capitalization of C$1.64 billion and generates C$267.16 million in revenue each year.

Aurora Cannabis employs 2,380 workers across the globe.

The official website for Aurora Cannabis is auroramj.com.

Aurora Cannabis is headquartered at 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada.

Aurora Cannabis' mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The company can be reached via phone at +1-604-3625207.